Targeting transcription factors with proximity-inducing drugs to prevent age-related vascular diseases
| Institution | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC) |
|---|---|
| Project leader | Michael Potente |
| Site | Berlin |
| Project type | Standortprojekt |
| Funding | € 270.058,00 |
| Begin | 01.01.2026 |
| End | 31.12.2030 |
Förderkennzeichen
81Z0100119
Projektnummer
2142